Latin American Leaders Seek New Housing Finance and Climate Resilience at World Urban Forum 13 Heard on the Street Writers Reveal Annual Stock Picks in Eighth Contest Edition Were Not in a Bubble Wall Street Just Hasnt Caught Up With the New Physics of the Stock Market EU Parliament Approves Controversial US Tariff Deal Amid Trade Policy Uncertainty Spotify Launches Legal AI Remix Feature Signaling Shift in Music Licensing Bitcoin ETFs See 226 Billion in Outflows Over TwoWeek Period VELO Q1 2026 Earnings Significant EPS Beat Drives Stock Surge WERN Q1 2026 Earnings Earnings Beat with Positive Surprise Amid Weak Demand Simpson Manufacturing Q1 2026 Earnings EPS Beats Estimates by 1285 as Profitability Holds Firm CLLS Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Despite No Revenue flyExclusive Inc FLYX Q1 2026 Earnings EPS Beats Estimates on NarrowerThanExpected Loss ODYS Q1 2026 Earnings EPS Misses Estimates as Company Focuses on Product Development Rigel Pharmaceuticals RIGL Holds Near Support Amid Modest Decline Liquidity Services Inc LQDT Surges 386 Analyzing the Breakout Potential Baozun Inc BZUN Rallies 36 as Shares Test Key Resistance Near 272 NCS Multistage Holdings NCSM Slips 135 as Traders Weigh Support at 4095 Adams Natural Resources Fund PEO Holds Steady Near 2643 After Marginal Gain Lessons from Ebola Outbreak Offer Insights for Healthcare Investment and Crisis Management FLGT Q1 2026 Earnings Significant EPS Miss Amid Revenue Discrepancy Futu Holdings Plunges Over 27 Key Support Levels in Focus Dogwood Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued Preclinical Development Six Flags Entertainment Q1 2026 Earnings Narrowerthanexpected loss amid seasonal headwinds Dianthus Therapeutics Q1 2026 Earnings EPS Beat Amid PreRevenue Stage FIS Q1 2026 Earnings EPS Surpasses Estimates by 464 as Stock Moves Lower GNLX Q1 2026 Earnings EPS Misses Estimates as Company Reports No Revenue Stepan Company SCL Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher Revelation Biosciences Inc REVB Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Continues Development